Pemetrexed for the treatment of malignant pleural mesothelioma

  • Technology appraisal guidance
  • TA135
  • Published: 

Pemetrexed for the treatment of malignant pleural mesothelioma: Appeal

An appeal hearing was held on 23 November 2007.  The Institute awaits the decision of the appeal panel.

This page was last updated: 30 March 2010